EUDA Strategically Expands into T-Cell Immunotherapy Strengthening Its Stem Cell Therapy Portfolio
| EUDA Stock | 2.95 0.18 5.75% |
About 59% of EUDA Health's investor base is looking to short. The analysis of overall sentiment of trading EUDA Health Holdings stock suggests that many investors are alarmed at this time. The current market sentiment, together with EUDA Health's historical and current headlines, can help investors time the market. In addition, many technical investors use EUDA Health Holdings stock news signals to limit their universe of possible portfolio assets.
SINGAPORE, Sept. 04, 2025 -- EUDA Health Holdings Limited , a leading Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia, and China, today announced that it has secured distribution rights for T-cell immunotherapies in Malaysia developed by Shenzhen Inno Immune Co. Ltd. , a developer of autologous cellular therapeutic and customized medicines for a wide range of diseases in China.
Read at finance.yahoo.com
![]() |
EUDA Health Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards EUDA Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
EUDA Health Fundamental Analysis
We analyze EUDA Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EUDA Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EUDA Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
EUDA Health is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
EUDA Health Holdings Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with EUDA Health stock to make a market-neutral strategy. Peer analysis of EUDA Health could also be used in its relative valuation, which is a method of valuing EUDA Health by comparing valuation metrics with similar companies.
Peers
EUDA Health Related Equities
| AMWL | American Well | 5.13 | ||||
| HYPR | Hyperfine | 2.73 | ||||
| GUTS | Fractyl Health, | 1.82 | ||||
| FONR | Fonar | 0.81 | ||||
| FORA | Forian | 0.46 | ||||
| ADVM | Adverum Biotechnologies | 0.92 | ||||
| DTIL | Precision BioSciences | 1.00 | ||||
| ZTEK | ZEN Graphene | 1.25 | ||||
| QNCX | Quince Therapeutics, | 3.91 | ||||
| ATYR | ATyr Pharma, | 6.51 |
Complementary Tools for EUDA Stock analysis
When running EUDA Health's price analysis, check to measure EUDA Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EUDA Health is operating at the current time. Most of EUDA Health's value examination focuses on studying past and present price action to predict the probability of EUDA Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EUDA Health's price. Additionally, you may evaluate how the addition of EUDA Health to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
